Your browser doesn't support javascript.
loading
Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
Kawasaki, Eiji; Oikawa, Yoichi; Okada, Akira; Kanatsuna, Norio; Kawamura, Tomoyuki; Kikuchi, Tadashi; Terasaki, Jungo; Miura, Junnosuke; Itoh, Yoshihisa; Hanafusa, Toshiaki.
Afiliación
  • Kawasaki E; Diabetes Center, Shin-Koga Hospital, Kurume, Japan.
  • Oikawa Y; Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Okada A; Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama, Japan.
  • Kanatsuna N; Okada Clinic, Fukuoka, Japan.
  • Kawamura T; Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan.
  • Kikuchi T; Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Terasaki J; Cosmic Corporation, Tokyo, Japan.
  • Miura J; Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan.
  • Itoh Y; Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Hanafusa T; Eiju General Hospital, Tokyo, Japan.
J Diabetes Investig ; 12(4): 510-515, 2021 Apr.
Article en En | MEDLINE | ID: mdl-32696593
AIMS/INTRODUCTION: This study aimed to investigate the dynamics associated with autoantibodies to insulinoma-associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) relating to the onset age and disease duration in patients with type 1 diabetes. METHODS: Using bridging-type enzyme-linked immunosorbent assay, IA-2A, ZnT8A and glutamic acid decarboxylase autoantibodies were evaluated in 269 patients with type 1 diabetes (median onset age 18.2 years, range 0.8-86 years; median diabetes duration 7 years, range 0-58 years). We then compared the prevalence of these autoantibodies among the different age groups, along with the duration of diabetes using the Cochran-Armitage trend test and multivariate logistic regression analysis. RESULTS: The prevalence of IA-2A, ZnT8A and glutamic acid decarboxylase autoantibodies in patients with duration of ≤3 years was 41.1, 36.7 and 72.2%, respectively, with 80.0% expressing one or more of these autoantibodies. This prevalence declined according to the disease duration (P < 0.005). Both IA-2A and ZnT8A were more frequently observed in younger patients, whereas glutamic acid decarboxylase autoantibodies was more common in older patients. Multivariate logistic regression analysis showed that there was a significant interaction between the onset age and duration of diabetes in patients diagnosed when aged ≤10 years regarding all anti-islet autoantibodies (P < 0.05). However, for patients diagnosed in the middle tertile (aged 11-30 years), the interaction was significant only for ZnT8A, and for those with late-onset diabetes (aged ≥31 years) only for IA-2A. CONCLUSIONS: The current study showed that the rate of disappearance of anti-islet autoantibodies is faster in patients aged ≤10 years, and that even though both proteins are localized in the insulin granule membrane, humoral autoimmunity to IA-2 and ZnT8 differs according to the age of onset.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Proteínas Tirosina Fosfatasas Clase 8 Similares a Receptores / Transportador 8 de Zinc / Glutamato Descarboxilasa Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Middle aged Idioma: En Revista: J Diabetes Investig Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Proteínas Tirosina Fosfatasas Clase 8 Similares a Receptores / Transportador 8 de Zinc / Glutamato Descarboxilasa Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Middle aged Idioma: En Revista: J Diabetes Investig Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón